Asmaa Javed | Erdheim-Chester Disease Global Alliance

Complete remission of critical neurohistiocytosis by vemurafenib

Dec 28, 2015

Philipp Euskirchen, MD, Julien Haroche, MD, PhD, Jean-François Emile, MD, PhD, Ralph Buchert, PhD, Staffan Vandersee, MD, Andreas Meisel, MD Neurol Neuroimmunol Neuroinflamm. 2015 Apr; 2(2): e78. doi: 10.1212/NXI.0000000000000078

Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid

Dec 28, 2015

E. N. Bulycheva, V. V. Baykov, M. I. Zaraĭskiĭ, and G. N. Salogub Case Rep Hematol. 2015; 2015: 876752. Published online 2015 Apr 8. doi: 10.1155/2015/876752

Erdheim-Chester Disease: A Case Report

Dec 28, 2015

Jean Alexiou and Jean Klastersky Am J Case Rep. 2015; 16: 361–366. Published online 2015 Jun 11. doi: 10.12659/AJCR.892750

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1

Dec 28, 2015

Zoran Gatalica, Nurija Bilalovic, Juan P. Palazzo, Ryan P. Bender, Jeffrey Swensen, Sherri Z. Millis, Semir Vranic, Daniel Von Hoff and Robert J. Arceci Oncotarget. 2015 Jun 8.

Filip Janku, MD, PhD

Oct 20, 2015

Complete remission of critical neurohistiocytosis by vemurafenib

Rare Form of Erdheim-Chester Disease Presenting with Isolated Central Skeletal Lesions Treated with a Combination of Alfa-Interferon and Zoledronic Acid

Erdheim-Chester Disease: A Case Report

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1

Filip Janku, MD, PhD

Search Our Blogs

Recent Posts

Back to Top

Join Us

Donate

Care Centers

Events